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O utlet strut fractures (OSFs) of Björk-Shiley con-vexo-concave (BSCC) valves (Shiley, Inc, Irvine,
Calif, a subsidiary of Pfizer, Inc) continue to be a con-
cern for approximately 35,000 nonexplanted patients
worldwide. Although reports of OSF events were high-
est in the 1980s, particularly among large mitral valves,
it is important to note that OSF events are still occur-
ring, and as of September 1999, over 600 events have
been reported to the manufacturer (Trustees for the
Bowling Pfizer Heart Valve Settlement Funds, personal
communication). Additionally, an underreporting of
10% to 25% for OSF events has been suggested in var-
ious studies.1-4 An increased risk of OSF for 23-mm
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aortic valves has emerged more recently in the United
Kingdom, with the last OSF reported in September
2000.
There has been much debate as to whether the problem
of OSF lies with the intrinsic valve design, specific char-
acteristics of the valve-manufacturing process, or patient
characteristics. Previous research has identified age at
implantation and body surface area as key patient factors
associated with the risk of OSF.1,2,5 No dominant clinical
factor of risk has been identified.1 Of the valve charac-
teristics investigated, large valve size, mitral position,
and a 70° opening angle are thought to be associated
with risk of OSF.2-4,6 With respect to the manufacturing
process, valves manufactured after 1981 in batches with
high fracture rates and welded by specific groups of
employees were reported to be at a high risk of OSF.1,6-8
The current guidelines9 for the patients and clinicians
concerning explant operations for BSCC valves include
these manufacturing and valve characteristics and cur-
rent age in predicting the risk of OSF. However, these
factors do not fully explain the risk with OSF events
occurring outside these parameters. The development of
guidelines for explant operations is a continuous process
and is updated on the basis of ongoing research. It is
therefore important to examine various aspects of the
valve-manufacturing process in detail to identify other
potential risk factors. Two studies have conducted in-
depth investigations on various manufacturing character-
istics of BSCC valves, but they differ in terms of factors
investigated and their findings.6,7
This article describes a case-control study nested
within the cohort study of patients with BSCC valves in
the United Kingdom.1 The objective of this study was
to examine the risk of OSF in relation to combined
characteristics of the manufacturing process investigat-
ed by Walker,6 Kallewaard,7 and their colleagues.
Additionally, information on a number of other manu-
facturing characteristics considered to be potential risk
factors for OSF were examined.
Methods
Selection of cases and controls. A nested case-control
study was conducted in which OSF events with supporting
documentation available up to the last follow-up date (July
31, 1997) of the UK cohort study were eligible to be cases.1
The case-control study includes 52 of the 56 OSF events
reported in this cohort study. Two of the OSF events occur-
ring within the last follow-up date of the cohort had docu-
mented evidence available at a later period. Manufacturing
records were not available for 2 further OSF events. Five con-
trol subjects were selected for each case from the study
cohort matched on age at implantation, valve position, and
size. However, 10 of the selected control subjects had to be
dropped from the study because of information received sub-
sequently, which made them ineligible for inclusion. It was
only possible to obtain 3 matching control subjects within the
study cohort for one 23-mm aortic OSF. The UK case-control
study thus comprises 52 cases with OSF events and 248
matched control subjects, including at least 3 matching con-
trol subjects for each case. Manufacturing records were
obtained from the manufacturer.
Data abstraction. The characteristics of the manufactur-
ing process of BSCC valves and related documentation have
been described extensively elsewhere6,7 and are only dis-
cussed briefly in this article. A simplified version of the man-
ufacturing process is presented in Fig 1 to assist the reader.
The main manufacturing characteristics, which were exam-
ined for association with the risk of OSF in the UK case-con-
trol study, are presented in Table I. The selection of factors
was based on a review of the manufacturer’s engineering
specifications, consultation with a metallurgist, and evalua-
tion of aspects of the manufacturing process investigated by
the studies of Walker,6 Kallewaard,7 and their colleagues.
Variables 1 to 5 in Table I pertain to information on the out-
let strut assembly production time, the manufacturing period,
the size of the production batch (lot size), and the percentage
of valves rejected in a batch during quality-control proce-
dures. These factors were considered to be a measure of the
quality of the batch of valves in which they were produced.
The remaining variables describe tasks performed on the
individual valve during the manufacturing process. Some
tasks, such as disc fit and assembly and disc pull, require
manipulation of the actual outlet strut of the valve. Factors
describing the extent of rework done on the valves included
the number of discs fitted to the valve, rewelding of deficient
welds, and removal of excess weld material by polishing
(relieve weld).
The flexibility tests were performed on the valves’ outlet
strut after the welding process to ascertain the amount of
deflection of the strut when subjected to a specific force or
load. Two types of flexibility tests known as the hook deflec-
tion test (HDT) and load deflection test (LDT) were carried
out, depending on when the valve was manufactured. The
HDT was replaced in February 1982 by the LDT; however,
valves that had production times crossing over from before
February 1982 to a later period and those that were recalled
could have undergone both types of tests. In performing an
HDT, a 7-kg weight was suspended from the outlet hook for
21- to 29-mm valves and a 5-kg weight for 19-mm valves.
After August 1981 and until its withdrawal, this test was
allowed to be performed more than once, usually after rework
on the valve. For an LDT, a 5-kg load was gradually placed
on the outlet strut, unloaded, and then reapplied.
The layout and information recorded on the manufacturing
documents changed over time, resulting in several different
versions, and were categorized by Kallewaard and col-
leagues7 to reflect the time period in which they were used.
The baggy card is a manufacturing document that records
information on standard assembly tasks and reworking, and
version 4 was most commonly used. This version pertains to
the manufacturing period from 1981-1982, which was
observed to be a risk factor for OSF.8,9
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A red tag often used to mark reworked valves was examined
as a surrogate for rework status. In addition, 2 other factors were
investigated, the disc-to-strut gap (DSG) and the presence of a
phantom welder. The DSG measures the maximum clearance
from the disc to the outlet strut at any opening angle of the valve.
It was thought that this could be a determinant for excess move-
ment of the disc within the struts. Two sets of measurements were
available for DSG taken before and after the sewing ring was fit-
ted to the valve. The phantom welder refers to the employee
number of an individual who was recorded on the manufacturing
records as having performed rewelding on specific valves but
was not employed by the manufacturer when the valves were
allegedly rewelded.7 Finally, shop-order fracture rate (SFR),
which was defined as the percentage of other valves in the same
batch for which an OSF event had been reported to the manufac-
turer, and manufacturing period were examined as risk factors.
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Table I. Results from univariate regression analyses on the basis of valves
Manufacturing characteristics Patients/control subjects Odds ratio 95% CI
Batch level documents
Size of lot to be assembled* <175 valves 25/117
≥175 valves 27/131 1.0 0.5-1.8
Production time per valve† >0.16 d (baseline) 14/85
0.12-0.16 d 27/89 2.1 1.0-4.6
<0.12 d 11/74 1.0 0.4-2.4
Manufacturing date Before 1981 (baseline) 4/43
1981-1984 48/205 3.8 1.0-13.7
SFR 52/248 1.3 1.1-1.5
Percentage of valves rejected 51/245 1.0 0.9-1.0
Individual valve documents
Baggy version Other versions (baseline) 14/67
Version 4 38/181 1.0 0.5-2.3
Disc fit recorded more than once No (baseline) 38/207
Yes 14/41 1.8 0.9-3.6
Final polish recorded more than once No (baseline) 40/199
Yes 12/42 1.4 0.7-3.0
No. of HDTs performed None (baseline) 34/158
1 14/88 0.7 0.3-1.5
≥2 4/2 8.1 1.4-45.8
Number of LDTs performed None (baseline) 16/106
1 34/125 2.8 1.5-6.8
≥2 2/17 1.2 0.3-6.4
Disc assembly recorded more than once No (baseline) 33/175
Yes 19/73 1.4 0.7-2.7
Relieve weld recorded more than once No (baseline) 47/230
Yes 5/23 1.4 0.5-4.1
Crack or weld noted No (baseline) 44/223
Yes 8/25 1.7 0.7-4.1
Disc pull noted No (baseline) 49/223
Yes 3/25 0.6 0.2-1.9
More than one disc used for this valve No (baseline)
Yes 1.5 0.4-5.5
Red mark noted No (baseline) 47/204
Yes 5/44 0.5 0.2-1.3
Disc-to-strut measurement‡ (inch) <0.012 (baseline) 7/75
0.012 18/86 2.6 1.0-6.9
0.013 7/42 2.4 0.7-7.8
>0.013 20/40 8.8 2.9-26.8
Disc-to-strut measurement§ (inch) <0.012 (baseline) 12/86
0.012 14/79 1.4 0.6-3.2
0.013 10/33 2.5 0.9-6.6
>0.013 16/49 2.9 1.1-7.3
Phantom welder present No (baseline) 50/242
Yes 2/6 1.6 0.3-8.0
Number of patients and control subjects for each variable may not always add up to 52 and 248, respectively, because of missing observations.
*Based on median lot size of the Dutch study for comparability.
†Based on tertiles.
‡Taken before sewing ring placement.
§Taken after sewing ring placement.
All documents were double data abstracted and entered.
Methods of data abstraction and coding were specifically
designed to be similar to those used in the investigation of
Kallewaard and colleagues.7 A conditional logistic regression
analysis was performed to examine the potential risk factors
in relation to OSF. All statistical analyses were carried out by
using the statistical software STATA (Stata Corporation,
College Station, Tex). Both univariate and multiple-regres-
sion analyses were performed. Variables that had been identi-
fied as risk factors in previous studies and also those for
which P values were .2 or less in the univariate analysis were
included in the multiple-regression analyses. A backward
elimination procedure10 was used to select the final model.
Results
There were 40 mitral OSF cases with 193 control
subjects and 12 valves with aortic OSFs with 55 control
subjects in the study. Table I presents the results from
the univariate regression analyses. Of all the variables
examined, manufacturing date, SFR, performance of a
multiple HDT, performance of an LDT, and DSG mea-
surements were found to have statistically significant
associations with the risk of OSF. There was a decrease
in the risk of OSF when an HDT was performed only
once. The excess risk associated with LDT was only
significant when performed once. It is somewhat diffi-
cult to disentangle the influence of these flexibility
tests from one another because 21 valves in this study
had undergone both HDT and LDT. Four of the 6
valves that had undergone multiple HDTs had also
undergone a single LDT. However, none of the valves
underwent both types of flexibility tests more than
once. Because of the small numbers, it was not possi-
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Fig 1. A simplified description of manufacturing procedures of BSCC heart valves. *Assessment of disc size, disc not fit-
ted. #Regurgitation tests completed. When valves fail at specific points in the manufacturing process, they are reworked
and will be returned to the failed test point or to an earlier process. **Valves manufactured before February 1982 under-
went HDT, and those manufactured later underwent LDT; some underwent both.
ble to conduct a further analysis investigating the risk
of OSF by grouping the valves according to whether
they had undergone only one type of flexibility test
(single and multiple) or a combination of both.
Results from the multiple-regression analyses are
presented in Table II. Initially, an analysis was con-
ducted, including only manufacturing characteristics
identified as the main risk factors in the study by
Kallewaard and colleagues (model 1).7 Age at implant,
which has been used as a matching factor in the study
design, was not included in this model. SFR and per-
formance of a multiple HDT were observed to be sig-
nificantly related to the risk of OSF, but lot size and the
number of discs fitted did not show any association. A
second multiple-regression analysis was performed to
identify significant risk factors for OSF on the basis of
the UK data (models 2 and 3). Manufacturing period
and LDT were not significant in these analyses, where-
as associations observed with SFR and multiple HDTs
remained significant. There was an increased risk in
OSF for DSG measurements of greater than 0.013 inch,
but the association was only significant for measure-
ments taken after the attachment of the sewing ring.
Similar results were obtained when the analyses were
restricted to large mitral valves only.
Six of the 20 cases that had a DSG of greater than
0.013 inch when measured before the attachment of the
sewing ring moved to a lower measurement category
after the attachment. A similar pattern was observed for
only 7 of the 40 control valves with a first DSG mea-
surement of greater than 0.013 inch. This resulted in
weakening the association with the second set of DSG
measurements, but the reason behind this differential
reduction is not clear.
Further investigation was made on the characteristics
of the 6 valves that underwent multiple HDTs. Some of
the manufacturing characteristics of these valves are
presented in Table III. Four of the valves had a crack or
reweld documented, and 2 experienced an OSF. Three
of the 4 valves that had also undergone an LDT had
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Table II. Results from multiple regression analyses on the basis of all valves
Model 2 Model 3 
(including first (including second 
Model 1 DSG measurement) DSG measurements)
Variables OR 95% CI OR 95% CI OR 95% CI
Size of lot assembled ≥175 valves* 1.0 0.5-1.9
More than 1 disc used for this valve† 0.8 0.1-5.2
Number of HDTs‡
1 0.5 0.2-1.3 0.8 0.3-2.1 0.5 0.2-1.4
≥2 7.5 1.1-50.6 8.9 1.3-61.4 7.0 1.1-45.5
Percentage of SFR 1.3 1.1-1.6 1.3 1.1-1.6 1.3 1.1-1.5
DSG (inch)§
0.012 1.7 0.6-4.8 0.8 0.3-2.2
0.013 1.6 0.5-5.8 1.6 0.6-4.6
>0.013 7.1 2.2-23.1 1.7 0.6-4.7
OR, Odds ratio.
*Baseline <175 valves.
†Baseline: one disc used.
‡No HDTs performed.
§Baseline: < 0.012 inch.
Table III. Some manufacturing characteristics of valves that underwent multiple HDTs
No. of Crack/ Phantom No. of times 
Valve Valve times disc LDTs reweld welder final polish No. of disc Disc 
Observations OSF position size fit recorded performed noted noted recorded assemblies pull
1 Yes Mitral 33 3 Yes Yes Yes 3 2 Yes
2 Yes Mitral 31 4 Yes No No 2 9 No
3 Yes Mitral 33 1 Yes No Yes 3 6 No
4 Yes Aortic 23 1 No Yes Yes 2 4 Yes
5 No Mitral 29 1 Yes Yes Yes 2 2 Yes
6 No Mitral 27 3 No Yes No 2 2 Yes
fractured. There was one OSF valve that had a disc fit-
ted 4 times, and 9 disc assembly procedures were
recorded. The median time taken for the valves under-
going multiple HDTs to fracture from the time of
implant (median, 5 years; range, 0.7-9.6 years) was
similar to that of the other OSF valves (median, 5 years;
range, 0.6-15.7 years) not undergoing multiple HDTs.
DSG measurements did not show any association either
with multiple HDTs or with rework.
Investigations were also made to see whether there
were any differences in the SFR, the number of HDTs
performed, and DSG measurements by manufacturing
period. The SFR and DSG measurements were smaller
before 1981. The SFR was highest during January 1,
1981, and June 1982, and all 6 valves that underwent
multiple HDTs were manufactured during that period.
Discussion
OSFs in BSCC valves continue to be a matter of con-
cern both for patients with BSCC valves and for clini-
cians. The UK cohort of BSCC patients has a longer
and more complete follow-up than that reported in
other published studies.1 The crude OSF rate in the
United Kingdom was estimated to be 0.17% per year,
the highest among all monitored populations. To date,
61 OSF events have been reported in the United
Kingdom, with 51 resulting in the death of the patient.
Eight OSF events have occurred within the last 5 years,
which include 5 aortic OSFs.
A changing pattern of OSF rates has been observed in
the UK cohort, with mitral OSF rates reducing over
time but without the same pattern for aortic OSF rates.
An excess risk has particularly been observed in 23-
mm aortic valves. Aortic OSFs usually result in instan-
taneous death and consequently may be underreported
to a greater extent. The excess in 23-mm aortic valves
has been seen in Sweden,3 where the postmortem rate
is high, but not in The Netherlands4 or the United
States.5 Accuracy of detecting OSF events in the United
Kingdom is thought to be high. All patients are tracked
by the Office of National Statistics and the Central
Services Agency for information on their vital status
and forwarding of death certificates for systematic
review. The postmortem rate in the United Kingdom is
30% for all deaths and 49% for sudden deaths. A larg-
er number of mitral valves than aortic valves have been
electively explanted in the United Kingdom because
the former were considered to be at greater risk. This
may partly explain the changing OSF patterns in the
United Kingdom.
The UK case-control study thus differs from other
studies with respect to a broader spectrum of valves
included and also a wider range of manufacturing char-
acteristics investigated. Kallewaard and colleagues7
only considered large mitral valves, including 26 OSF
events (half the number included in the UK study), and
identified performance of multiple HDTs, number of
discs fitted to the valve, and lot size as risk factors. The
finding of multiple HDTs has been confirmed in the
United Kingdom, with a sizeable increase in the risk of
OSF associated with this factor (7- to 9-fold risk), but
associations with the other factors were not observed.
The application of a large weight to the outlet strut dur-
ing the HDT may have been excessive, although only
multiple HDTs were associated with increased risk of
OSF, and a reapplication may cause permanent defor-
mation. Of the 4 OSF valves that had undergone multi-
ple HDTs in the UK case-control study, some also had
a crack or reweld documented and had undergone an
additional flexibility test (LDT). After adjusting for
these factors, multiple HDTs remained significant;
however, it is not possible to conclude definitely that
multiple HDTs on their own are causal risk factors for
OSF. Nevertheless, it is clear that multiple HDTs are a
marker for excess risk.
Walker and colleagues6 did not investigate the num-
ber of times the valves underwent an HDT or LDT but
reported statistically nonsignificant excess risk with
flexible struts. This finding could not be investigated in
the United Kingdom because deflection measurements
for valves that underwent HDTs and had results record-
ed only included 18 of the cases.
A high risk of OSF was observed with large DSG
measurements but was only significant for the first set
of measurements. A large gap could be indicative of the
fact that the outlet strut is a long way forward from the
edge of the disc, which could predispose the disc on
overrotation to impact the strut above the weld area. It
could also be an indication of incorrect seating of the
disc on the inlet strut. However, it is difficult to draw
definite conclusions regarding the DSG measurements.
Excess risk was associated with gaps of greater than
0.013 inch for both sets of measurements but was only
significant for the first set. The measurements were
taken before and after the attachment of the sewing ring
by different observers. The differences may be attrib-
uted to one or both of these factors. One could specu-
late that the measurements taken after the attachment
of the sewing ring are more relevant because these
measurements were taken before the valves were dis-
patched for implantation. Walker and colleagues6
found a nonsignificant protective effect for DSG mea-
surements of less than 0.010 inch; however, they did
not mention whether the results were based on the first
1148 Omar et al The Journal of Thoracic and
Cardiovascular Surgery
June 2001
or the second set of measurements. Kallewaard and
colleagues7 did not report findings on this factor.
Body surface area has been identified as a risk factor
for OSF.1,5 The association with body surface area could
not be investigated when HDT was included in the
model because information on body surface area was not
available in 2 of the 4 valves undergoing multiple HDTs
that had experienced an OSF. However, body surface
area remained significant after adjusting for SFR, manu-
facturing period, and DSG measurements.
Wieting and colleagues11 suggest a plausible combi-
nation of valve and patient factors as prerequisites for
valve failure. In particular, they indicate that a mechan-
ical load associated with an overrotation of the disc on
closing could cause impact of the disc with the outlet
strut. This, combined with patient physiology and valve
geometric factors, is likely to be responsible for the
observed fractures. On over-rotation, impacts at the tip
of the strut or above the weld base may cause failure.
Changes to the inspection process after April 1984
made certain that the former condition could not occur
on a valve passing the inspection tests. These changes
ensured correct alignment of the disc against the inlet
strut in the closed position so that should the disc over-
rotate there would be no possibility of impact on the
outlet strut leg in the area above the weld. No OSF
events have been reported worldwide in valves manu-
factured after this period. Within the case-control study,
it was therefore not possible to ascertain whether the
DSG measurements had changed after the introduction
of the tests in early 1984.
It is our view that a combination of factors related to
patients, design of the valves, and the manufacturing
process are responsible for OSF of BSCC valves.
Multiple HDTs have emerged in both The Netherlands
and the United Kingdom as a potential new risk factor
for OSF, and the estimated risk associated with it is one
of the largest compared with other previously identified
risk factors. To prepare guidelines to enable clinicians
and patients to make decisions for explant operations,
it is important to use risk factors that have been vali-
dated across studies and for which information can eas-
ily be obtained. A further study is needed to explore the
factors correlated with multiple HDTs. On confirma-
tion as a risk factor, the presence of multiple HDTs
may be added to the models used to predict OSF risk,
thus influencing decisions regarding the eligibility of
patients for explant operations.
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